Skip to main content

David A Cabezas, MD

Pathologist

Rated 4.6 out of 5 stars
Photo of David A Cabezas

My publications

6 publications

2023

In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies.

Journal of biomolecular structure & dynamics

PubMed • Publisher's site

2022

Design, Synthesis, In Silico Studies and Inhibitory Activity towards Bcr-Abl, BTK and FLT3-ITD of New 2,6,9-Trisubstituted Purine Derivatives as Potential Agents for the Treatment of Leukaemia.

Pharmaceutics

PubMed • Publisher's site

2021

Novel N-Arylsulfonylindoles Targeted as Ligands of the 5-HT6 Receptor. Insights on the Influence of C-5 Substitution on Ligand Affinity.

Pharmaceuticals (Basel, Switzerland)

PubMed • Publisher's site

2020

Synthesis, Docking, 3-D-Qsar, and Biological Assays of Novel Indole Derivatives Targeting Serotonin Transporter, Dopamine D2 Receptor, and Mao-A Enzyme: In the Pursuit for Potential Multitarget Directed Ligands.

Molecules (Basel, Switzerland)

PubMed • Publisher's site